Strategies to Increase Access to Hepatitis C (HCV) Treatment within ADAPs: Provider Decision Tree

Last Updated

NASTAD continues work to ensure that individuals coinfected with HIV and hepatitis C virus (HCV) can gain access to curative treatments for HCV via the Health Resources and Services Administration’s (HRSA) Ryan White HIV/AIDS Program’s (RWHAP) AIDS Drug Assistance Programs (ADAPs).  Many providers do not maximize all available HCV treatment opportunities, instead relying solely on pharmaceutical companies’ patient assistance and cost-sharing assistance programs. NASTAD has developed a decision tree for providers to illustrate and clarify the myriad treatment coverage options available to people living with HIV and HCV, including ADAP.  ADAPs are encouraged to share this resource with local HIV/HCV service providers, including those who work outside of the RWHAP.